PharmaVoice

JUNE 28, 2022

A new report from IQVIA reveals the current challenges — and promise — in cancer drug R&D.

189

189

Pharmacy Times

JUNE 28, 2022

Clorazepate dipotassium tablets are for the management of anxiety disorders or for the short-term relief of symptoms.

FDA 132

FDA 132

European Pharmaceutical Review

JUNE 28, 2022

According to recent market research , the global market for biopharmaceutical bioseparation systems, estimated to value $13 billion in 2022, is projected to grow to $19.6 billion by 2026, achieving a compound annual growth rate (CAGR) of 13.2 percent. The analysts suggest the rising demand for biopharmaceuticals, equipment advancements and the pharma industry’s increasing focus on production efficiency are propelling growth in the global bioseparation systems market, as is the growing use of sin

Compounding 111

Compounding Dosage 111

Pharmacy Times

JUNE 28, 2022

At 1 month, a 50-µg booster dose of mRNA-1273.214 had a potent neutralizing antibody response against the Omicron variants in all individuals, regardless of prior infection.

123

123

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

European Pharmaceutical Review

JUNE 28, 2022

The post Guide to Data Integrity appeared first on European Pharmaceutical Review.

105

105

Pharmacy Times

JUNE 28, 2022

Olopatadine stabilizes ocular mast cells to prevent histamine release by allergens.

123

123

Pharmacy Times

JUNE 28, 2022

This month features Ozempic, Igalmi, and Triumeq PD.

123

123

Pharmaceutical Commerce

JUNE 28, 2022

Amy Shortman outlines some ways visibility technology is solving problems at a time when it’s needed most, and how digitization is the key to overcoming supply chain crises.

98

98

Pharmacy Times

JUNE 28, 2022

This month, we reviewed key topics and interviews from the American Society of Clinical Oncology 2022 Annual Meeting.

121

121

European Pharmaceutical Review

JUNE 28, 2022

New data reveals that more relapsing multiple sclerosis (RMS) patients continuously treated with Kesimpta ® (ofatumumab) had no evidence of disease activity (NEDA) versus switching from teriflunomide. 1. The Phase III Asclepios I/II trials and the Alithios open-label extension from Novartis , showed that earlier initiation with Kesimpta resulted in a more than three-fold increased likelihood of maintaining NEDA-3 throughout the study.

Labelling 98

Labelling Hospitals 98

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

JUNE 28, 2022

Investigators studied the efficacy and safety of eptinezumab-jjmr in the 100 mg and 300 mg intravenous infusion dosages in individuals with 2 to 4 documented unsuccessful prior preventive treatment failures for migraine in the past 10 years.

Documentation 94

Documentation Dosage 94

European Pharmaceutical Review

JUNE 28, 2022

HIGHLY POTENT active pharmaceutical ingredients (HPAPIs) products are classified based on their toxicity through occupational exposure limits (OELs). These molecules are proven to be effective at much smaller dosage levels than traditional APIs. Some examples of HPAPIs are cytotoxic compounds and hormones such as oestrogen. What defines ‘high potency’?

Compounding 96

Compounding Dosage 96

Outsourcing Pharma

JUNE 28, 2022

An expert from the decentralized trial solutions company shares how eCOA and ePRO can be useful tools that improve the collection and quality of such data.

90

90

Pharma Manufacturing

JUNE 28, 2022

Advanced digital thread and technology transfer capabilities can help pharma reap the benefits of its processes

75

75

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Outsourcing Pharma

JUNE 28, 2022

The pharmaceutical company is expanding its alliance with historically Black medical schools to bolster the battle against systemic health disparities.

Medical Schools 76

Medical Schools Pharmaceutical Companies Pharmaceutical Companies 76

Pharmacy Times

JUNE 28, 2022

Preetesh Jain, MBBS, MD, DM, PhD, offers perspective on unmet needs in treatment of patients with relapsed/refractory mantle cell lymphoma.

65

65

Pharmaceutical Technology

JUNE 28, 2022

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended granting approval for AstraZeneca and Merck’s (MSD outside the US and Canada) Lynparza (olaparib) as adjuvant therapy for high-risk early breast cancer patients. The treatment is intended for breast cancer patients with germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative who have previously received neoadjuvant or adjuvant chemotherapy.

Research Laboratories 64

Research Laboratories Chemotherapy 64

Pharmacy Times

JUNE 28, 2022

Ryan Haumschild, PharmD, MS, MBA, leads a discussion regarding the treatment of relapsed/refractory mantle cell lymphoma in the presence of comorbidities.

65

65

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmaceutical Technology

JUNE 28, 2022

Researchers at the Rensselaer Polytechnic Institute in the US have received a five-year, $3.5m grant from the National Institutes of Health (NIH) unit National Institute of Allergy and Infectious Diseases (NIAID) for developing a Covid-19 oral antiviral drug. The antiviral will be a low-dose drug which can be taken in the at-home setting. The latest research is part of the consortium of a new antiviral drug development centre named Center for Antiviral Medicines and Pandemic Preparedness (CAMPP)

FDA 59

FDA 59

Pharmacy Times

JUNE 28, 2022

Walgreens announced full ownership of AllianceRx Walgreens Prime in January, necessitating the name change to AllianceRx Walgreens Pharmacy.

65

65

The Happy PharmD

JUNE 28, 2022

Focused During Adversity – Alex Barker, PharmD. Exposing my secret and overcoming my adversities over the last year. I’ve been keeping a secret from you over the past year as I’ve struggled with family members’ health and my own mental health. Listen to the full episode at the link below: [link]. In this interview with Mike Koelzer from The Business of Pharmacy , I finally talk about exactly what I’ve been going through.

52

52

Pharmacy Times

JUNE 28, 2022

Dual action for neuropathy and neuralgia pain relief as well as for use in diabetes-related nerve pain and shingles.

65

65

Pharmaceutical Technology

JUNE 28, 2022

Mentions of robotics within the filings of companies in the pharmaceutical industry fell 22% between the final quarter of 2021 and the first quarter of 2022. In total, the frequency of sentences related to robotics between April 2021 and March 2022 was as frequent as in 2016 when GlobalData, from whom our data for this article is taken, first began to track the key issues referred to in company filings.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Omnicell Documentation 52

Pharmacy Times

JUNE 28, 2022

Levetiracetam is an anticonvulsant used to treat epileptic seizures.

65

65

Outsourcing Pharma

JUNE 28, 2022

The Bill and Melinda Gates Foundation grant, awarded to data management platform Flywheel, will support pediatric brain development in impoverished areas.

52

52

PharmExec

JUNE 28, 2022

Board Certified Biologics and Biosimilars Specialist (BCBBS) program will launch in 2022.

52

52

pharmaphorum

JUNE 28, 2022

Basilea Pharmaceutica may finally be able to bring its antibiotic ceftobiprole to the US market – 13 years after its first attempt was turned down – thanks to a new phase 3 clinical trial. The intravenously-administered cephalosporin drug met its objectives in the ERADICATE study in adults with bacterial bloodstream infections caused by Staphylococcus aureus (SAB), setting up an FDA filing before the end of the year, said the Swiss pharma.

FDA 52

FDA Hospitals 52

Pharmaceutical Commerce

JUNE 28, 2022

The latest people news happenings over the past month.

52

52

pharmaphorum

JUNE 28, 2022

SAE Media Group is delighted to announce the 2nd Annual Conference Oligonucleotide Therapeutics & Delivery, taking place on the 21st and 22nd September 2022 in London, UK. The 2022 Conference theme is on the latest advances in oligonucleotide discovery and delivery. Chairs for the conference are industry expert Ekkehard Leberer, Senior Consultant, Elbiocon, and Jim Weterings, Principal Scientist, AstraZeneca.

52

52

Pharma Times

JUNE 28, 2022

New data will be released at the International Society on Thrombosis and Haemostasis Congress

49

49

pharmaphorum

JUNE 28, 2022

Digital health company Health2Sync will work with Sanofi on digitising its range of insulin products in Japan, extending an earlier alliance in other markets. Health2Sync provides patient management software for doctors and mobile app for patients that is designed to help them improve blood glucose control by encouraging adherence – for example by logging insulin doses – and provides advice on managing symptoms and potential side effects of therapy.

Communication 52

Communication 52

Pharma Times

JUNE 28, 2022

The mobile clinics will support communities with limited or no access to vaccines and other health services

Vaccines 49

Vaccines 49

PharmaVoice

JUNE 28, 2022

The hormonal and genetic test developed by Adyn is designed to predict and prevent adverse birth control side effects.

240

240